Stage IIIB Lung Non-Small Cell Cancer AJCC v7 Active Not Recruiting Phase 2 Trials for Erlotinib (DB00530)

IndicationStatusPhase
DBCOND0115716 (Stage IIIB Lung Non-Small Cell Cancer AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00126581Erlotinib Hydrochloride With or Without Carboplatin and Paclitaxel in Treating Patients With Stage III-IV Non-small Cell Lung CancerTreatment